Status:
UNKNOWN
Integrated Care Pathway for Youth Depression
Lead Sponsor:
Centre for Addiction and Mental Health
Collaborating Sponsors:
Sunnybrook Health Sciences Centre
Conditions:
ICP1
Depression
Eligibility:
All Genders
14-18 years
Phase:
NA
Brief Summary
Major Depressive Disorder in adolescence is prevalent and debilitating. Our group aims to improve treatment response through the use of an Integrated Care Pathway (ICP) based on a high quality Clinica...
Detailed Description
Background: There is a gap between what is known from the evidence about the treatment of adolescent depression and what is practiced. Moreover, while there is evidence that measurement-based care can...
Eligibility Criteria
Inclusion
- Psychiatrist's impression is that depression is a primary psychiatric. concern
- 14-18 years old.
- DSM-5 criteria for Major Depressive Disorder or Persistent Depressive Disorder as per the Diagnostic Interview for Affective Symptoms for Children (DIAS-C19).
- Speak, read and write English at a grade 6 level.
Exclusion
- Threshold psychotic symptoms.
- Bipolar disorder.
- Moderate-to-severe substance use disorder.
- Autistic spectrum disorder or intellectual disability.
- Eating disorder.
- Suicide-related behaviours requiring acute intervention.
Key Trial Info
Start Date :
March 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 21 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03428555
Start Date
March 29 2018
End Date
February 21 2020
Last Update
August 9 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4Y 3M5
2
The Center for Addiction and Mental Health
Toronto, Ontario, Canada, M6J 1H4